Evidence map›Paper›PMID 36493463›Full record

ArticleBiometrics2023

Efficient and robust approaches for analysis of sequential multiple assignment randomized trials: Illustration using the ADAPT-R trial.

Lina M Montoya, Michael R Kosorok, Elvin H Geng, Joshua Schwab, Thomas A Odeny, Maya L Petersen

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Biometrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02338739 (An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02338739 nacompletednot on this map

An Adaptive Strategy for Preventing and Treating Lapses of Retention in Adult HIV Care (AdaPT-R)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2015 to 2020Enrolled1,816ConditionsHIVArmsREC, Outreach if Failure, REC, SMS + Voucher if Failure, REC
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effects Among the Affected.Statistics in medicine · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. A causal roadmap for generating high-quality real-world evidence.Journal of clinical and translational science · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lina M MontoyaDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-0975-4306
Michael R KosorokDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Elvin H GengDivision of Infectious Diseases, Washington University in St. Louis, St. Louis, Missouri, USA.
Joshua SchwabDivision of Biostatistics, School of Public Health, University of California, Berkeley, California, USA.
Thomas A OdenyCenter for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Maya L PetersenDivision of Biostatistics, School of Public Health, University of California, Berkeley, California, USA.
University of California, Berkeley · USUniversity of North Carolina at Chapel Hill · USWashington University in St. Louis · US

Funding

Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
What works, for whom? Applying novel precision medicine methods to people with mental illness in the justice system.K99MH133985 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MONTOYA, LINA · 2023 to 2023
$100k
Personalized strategies for HIV treatment maintenance: an application of novel machine learning methods to HIV care in East AfricaF31AI140962 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI MONTOYA, LINA · 2019 to 2020
$79k
NIAID NIH HHS F31 AI140962NIAID NIH HHS K24 AI134413NIAID NIH HHS R01 AI074345NIMH NIH HHS K99 MH133985
6 · The paper itself

Abstract

Personalized intervention strategies, in particular those that modify treatment based on a participant's own response, are a core component of precision medicine approaches. Sequential multiple assignment randomized trials (SMARTs) are growing in popularity and are specifically designed to facilitate the evaluation of sequential adaptive strategies, in particular those embedded within the SMART. Advances in efficient estimation approaches that are able to incorporate machine learning while retaining valid inference can allow for more precise estimates of the effectiveness of these embedded regimes. However, to the best of our knowledge, such approaches have not yet been applied as the primary analysis in SMART trials. In this paper, we present a robust and efficient approach using targeted maximum likelihood estimation (TMLE) for estimating and contrasting expected outcomes under the dynamic regimes embedded in a SMART, together with generating simultaneous confidence intervals for the resulting estimates. We contrast this method with two alternatives (G-computation and inverse probability weighting estimators). The precision gains and robust inference achievable through the use of TMLE to evaluate the effects of embedded regimes are illustrated using both outcome-blind simulations and a real-data analysis from the Adaptive Strategies for Preventing and Treating Lapses of Retention in Human Immunodeficiency Virus (HIV) Care (ADAPT-R) trial (NCT02338739), a SMART with a primary aim of identifying strategies to improve retention in HIV care among people living with HIV in sub-Saharan Africa.

Indexed as

HIV InfectionsHumansProbabilityRandomized Controlled Trials as Topicdynamic treatment regimesprecision medicinesequential multiple assignment randomized trialtargeted maximum likelihood estimation

Identifiers

PMID36493463
PMCPMC10424093
OpenAlexW4311018634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.